Graphite Bio Q2 EPS $(3.45) Down From $(0.56) YoY

Graphite Bio (NASDAQ:GRPH) reported quarterly losses of $(3.45) per share. This is a 516.07 percent decrease over losses of $(0.56) per share from the same period last year.

byBenzinga Newsdesk

August 12, 2021

1 minute read

Graphite Bio (NASDAQ:GRPH) reported quarterly losses of $(3.45) per share. This is a 516.07 percent decrease over losses of $(0.56) per share from the same period last year.

Jefferies Initiates Coverage On Vitesse Energy with Buy Rating, Announces Price Target of $23

By Benzinga Newsdesk

Today, 7:44 AM

Jefferies analyst Lloyd Byrne initiates coverage on Vitesse Energy (NYSE:VTS) with a Buy rating and announces Price Target of $23.

VTS

Earlier Announced Termination Of Dipraglurant Phase 2b/3 Study In Patients With Dyskinesia Associated With Parkinson’s Disease due To Slow Recruitment Rate; Co. Also Announced Suspension Of Guidance Amid Termination

By Bill Haddad

Today, 7:44 AM

COVID-19 related challenges negatively impacted patient recruitment Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 17, 2022- Addex Therapeutics

ADXN